TAKHZYRO
As listed in the register: TAKHZYRO 150 mg, solution injectable en seringue préremplie
150 mg · solution injectable
- Prescription only
- Active substance
- Lanadélumab
- Made by
- TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE) |
|---|---|
| Active substance | Lanadélumab |
| Strength | 150 mg |
| Form | solution injectable |
| Route | sous-cutanée |
| Dispensing (as stated by the register) | prescription hospitalière · liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/18/1340 |
| Name in the register | TAKHZYRO 150 mg, solution injectable en seringue préremplie |
| Packs | 1 seringue(s) préremplie(s) en verre de 1 ml |
| CIS | 67650090 |
| CIP13 | 3400930280300 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution injectable3 products
- 150 mg
300 mg2
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.